BioSpace News Archive

Business

ArQule Reports Second Quarter 2019 Financial Results

Conference call scheduled today at 9:00 a.m. ET

August 7, 2019
·
10 min read
Business

XyloCor Therapeutics Names Rickey Reinhardt, MD, PhD, Chief Medical Officer

Recognized industry leader to head clinical development programs

August 7, 2019
·
4 min read
Pharm Country

New KEDRAB® Dose Calculator Launches to Help Hospitals in Treating Rabies Exposures

Rabies is a fatal disease that can be prevented through post-exposure prophylaxis, which involves thorough wound cleansing, administration of human rabies immune globulin and a full course of rabies vaccine.

August 7, 2019
·
5 min read
Business

Rocket Pharmaceuticals Reports Second Quarter 2019 Financial Results and Operational Highlights

First Patient Dosed in RP-A501 Trial for Danon Disease

August 7, 2019
·
9 min read
Business

Moderna Provides Business Updates and Reports Second Quarter 2019 Financial Results

Phase 2 Personalized Cancer Vaccine (mRNA-4157) study initiated, with first patient consented

August 7, 2019
·
19 min read
Business

Tangen Biosciences Awarded Expanded Second Phase of Contract

Awarded the second phase of a contract to develop a field-deployable Anthrax diagnostic assay and expand the research to an antimicrobial resistance diagnostic assay.

August 7, 2019
·
3 min read
Business

Ra Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Initiation of single, pivotal, 12-week, Phase 3 gMG clinical trial on track for the second half of 2019

August 7, 2019
·
8 min read
Business

Acerus Reports Second Quarter and Year to Date Fiscal 2019 Financial Results

Strengthened balance sheet with US$5 million subordinated secured loan facility in July

August 7, 2019
·
18 min read
Business

Teva Reports Second Quarter 2019 Financial Results

Revenues of $4.3 billion

August 7, 2019
·
41 min read
Business

Teva Announces CFO Leadership Transition

Teva has initiated a search to identify its next CFO. Mr. McClellan is expected to remain in his role through the announcement of third quarter results to assist with a smooth transition.

August 7, 2019
·
3 min read